Gilead says remdesivir data show reduced risk of death

July 2020 Financial Times; Gilead Sciences revealed more trial data on Friday showing its experimental Covid-19 drug significantly reduced the risk of death, an early sign that the antiviral treatment may go beyond just speeding up recovery.  The California-based biotech group said its remdesivir treatment showed a 62 per cent …

Read More »